drugset / Trial / NCT02169934

A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 in Healthy Male Subjects

NCT02169934

Phase 1 Completed 6 enrolled Trevena Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the routes of excretion for TRV130 and it's metabolites, and to determine and characterize, structurally, the metabolites present in plasma, urine, and feces in healthy male subjects.

Timeline

Start
2014-06
Primary completion
2015-01
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Oliceridine Other / unclassified 2 mg Intravenous

Indications

No indication recorded.